Search Results - "Melchner, D"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Enhancing neurosteroid synthesis--relationship to the pharmacology of translocator protein (18 kDa) (TSPO) ligands and benzodiazepines by Wolf, L, Bauer, A, Melchner, D, Hallof-Buestrich, H, Stoertebecker, P, Haen, E, Kreutz, M, Sarubin, N, Milenkovic, V M, Wetzel, C H, Rupprecht, R, Nothdurfter, C

    Published in Pharmacopsychiatry (01-03-2015)
    “…The treatment of anxiety disorders is still a challenge; novel pharmacological approaches that combine rapid anxiolytic efficacy with fewer side effects are…”
    Get more information
    Journal Article
  2. 2

    Translocator Protein (TSPO) Expression in Platelets of Depressed Patients Decreases during Antidepressant Therapy by Sarubin, N, Baghai, T C, Lima-Ojeda, J M, Melchner, D, Hallof-Buestrich, H, Wolf, L, Hilbert, S, Milenkovic, V M, Wetzel, C H, Rupprecht, R, Nothdurfter, C

    Published in Pharmacopsychiatry (01-09-2016)
    “…A promising candidate in the field of pharmacological treatment options regarding major depressive disorder (MDD) is the mitochondrial translocator protein (18…”
    Get more information
    Journal Article
  3. 3
  4. 4
  5. 5